The DOI matches its Crossref record.
Breast carcinoma survival in Europe and the United States: A population‐based study
Open accessAbstract
BACKGROUND: Breast carcinoma survival rates were found to be higher in the U.S. than in Europe. METHODS: Multiple regression analysis of breast carcinoma survival rates among women diagnosed between 1990 and 1992 was performed using clinical data from population‐based case series from the Surveillance, Epidemiogy, and End Results (SEER) program (13,172 women) and the European Concerted Action on survival and Care of Cancer Patients (EUROCARE) project (4478 women). RESULTS: Early‐stage tumors (T1N0M0) were more frequent in the SEER data (41% of cases) than in the EUROCARE data (29%). In the SEER data, early tumors were more frequent in women age ≥ 65 years (43%) than in younger women (38%), whereas the reverse was true in the European data (25% vs. 31%). In both case series, > 90% of women underwent surgery and 81–82% underwent lymphadenectomy, but the number of axillary lymph nodes evaluated was higher in the SEER data than in the EUROCARE data. The 5‐year survival rate was higher in the U.S. case series (89%) than in the European series (79%). This differential was observed for each stage category evaluated: early (T1N0M0), large lymph node‐negative (T2–3N0M0), lymph node‐positive (T1–3N+M0), locally advanced (T4M0), and metastatic (M1) tumors. The overall relative excess risk (RER) of death was significantly higher (RER, 1.37; 95% confidence interval [95% CI], 1.25–1.50) among European women compared with U.S. women (referent group). Adjustment for stage, age, surgery, and the number of lymph nodes evaluated explained most of the excess risk (RER, 1.07; 95% CI, 0.98–1.17). CONCLUSIONS: Transatlantic differences in the 5‐year survival rates for women diagnosed with breast carcinoma between 1990 and 1992 were attributable mainly to differences in stage of disease. Resources should be invested to achieve earlier diagnosis of breast carcinoma in Europe, especially for elderly women. Cancer 2004;100:715–22. © 2003 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gianni, L., Eiermann, W., Semiglazov, V., Manikhas, A., Lluch, A., Tjulandin, S., Zambetti, M., Vazquez, F., Byakhow, M., Lichinitser, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61964-4 · Cited by 1,255
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Self-citationBadwe, R., Hawaldar, R., Nair, N., Kaushik, R., Parmar, V., Siddique, S., Budrukkar, A., Mittra, I., & Gupta, S. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00135-7 · Cited by 592
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Hortobagyi, G. N., de la Garza Salazar, J., Pritchard, K., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H., Liu, M.-C., Martin, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586
Anderson, B. O., Yip, C.-H., Smith, R. A., Shyyan, R., Sener, S. F., Eniu, A., Carlson, R. W., Azavedo, E., & Harford, J. (2008) · Cancer · doi:10.1002/cncr.23844 · Cited by 533
Metadata
- Authors
- Sant, M., Allemani, C., Berrino, F., Coleman, M. P., Aareleid, T., Chaplain, G., Coebergh, J. W., Colonna, M., Crosignani, P., Danzon, A., Federico, M., Gafà, L., Grosclaude, P., Hédelin, G., Macè‐Lesech, J., Garcia, C. M., Møller, H., Paci, E., Raverdy, N., Tretarre, B., Williams, E. M. I., & European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-02-03
- Volume
- 100
- Issue
- 4
- Pages
- 715-722
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1511271751
- Cited by
- 208
- References
- 0
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Breast carcinoma survival in Europe and the United States: A population‐based study. https://app.cochat.ai/papers/10.1002/cncr.20038
- The paper
- Sant, M., Allemani, C., Berrino, F., Coleman, M. P., Aareleid, T., Chaplain, G., Coebergh, J. W., Colonna, M., Crosignani, P., Danzon, A., Federico, M., Gafà, L., Grosclaude, P., Hédelin, G., Macè‐Lesech, J., Garcia, C. M., Møller, H., Paci, E., Raverdy, N., . . . European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group. (2004). Breast carcinoma survival in Europe and the United States: A population‐based study. Cancer. https://doi.org/10.1002/cncr.20038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
